Merck pneumococcal vaccine lands FDA nod, keeping up competition with Pfizer,

Merck tested Vaxneuvance in seven randomized, double-blind Phase 2 and 3 clinical trials. Those studies were not placebo controlled. For some …, Merck tested Vaxneuvance in seven randomized, double-blind Phase 2 and 3 clinical trials. Those studies were not placebo controlled. For some …, Read More

Scroll to Top